Assuming the lower end of 7m EBITDA eventuates... And available cash sits at even 2m, then it's trading at EV/EBITDA of under 7 (48/7)Given the relative valuation to all other wrap platforms, it's quite cheap.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025